SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-10-000703
Filing Date
2010-08-13
Accepted
2010-08-13 15:15:11
Documents
4
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED JUNE 30, 2010 nymox6kq2100630.htm 6-K 5360
2 QUARTERLY REPORT FOR THE QUARTER ENDED JUNE 30, 2010 exhibit99-1.htm EX-99.1 299941
3 SOX SECTION 302 AND 906 CEO CERTIFICATIONS exhibit99-2.htm EX-99.2 6001
4 SOX SECTION 302 AND 906 CFO CERTIFICATIONS exhibit99-3.htm EX-99.3 6068
  Complete submission text file 0001176256-10-000703.txt   318834
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 101015009
SIC: 2835 In Vitro & In Vivo Diagnostic Substances